Lonza Group Ltd

LO3

Company Profile

  • Business description

    Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.

  • Contact

    Muenchensteinerstrasse 38
    Basel4002
    CHE

    T: +41 613168111

    E: [email protected]

    https://www.lonza.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    18,686

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,829.202.500.03%
CAC 407,902.2523.790.30%
DAX 4024,456.8192.75-0.38%
Dow JONES (US)44,650.64192.340.43%
FTSE 1008,975.66108.641.23%
HKSE24,033.124.750.02%
NASDAQ20,630.6619.330.09%
Nikkei 22539,711.1864.820.16%
NZX 50 Index12,749.9210.28-0.08%
S&P 5006,280.4617.200.27%
S&P/ASX 2008,588.800.40-0.00%
SSE Composite Index3,505.963.72-0.11%

Market Movers